Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir
Keyword(s):
Keyword(s):
1997 ◽
Vol 27
(5)
◽
pp. 691-726
◽
Keyword(s):
Keyword(s):
1996 ◽
Vol 54
◽
pp. 636-637
1982 ◽
Vol 46
(6)
◽
pp. 314-322